The U.S. Food and Drug Administration has granted breakthrough therapy designation to Sanofi’s (SNY) venglustat, a novel, ...
Researchers show that pharmacological activation of hypoxia signaling improves metabolism, limits fat accumulation, and ...
Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...
In the open-label FIBROMET trial, metformin treatment was associated with reductions in bone marrow fibrosis and downregulation of key oncogenic signaling pathways in patients wit ...
Obesity is widely known for increasing the risk of diabetes and cardiovascular disease, but its damaging effects on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results